Subscribe To
Johnson & johnson sues doctors over studies linking talc-based products and cancer
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Showe...
July 13, 2023, 7:57 pm
Pepsico cfo on pricing, demand tailwinds and aspartame
PepsiCo CFO Hugh Johnston discusses the company's raised sales forecast, pricing and the potential impact of aspartame ...
July 13, 2023, 3:02 pm
Kura oncology: targeted aml therapy continues to deliver
Kura Oncology, Inc. has additional updated results released from the KOMET-001 study, as part of an oral late-breaker presentation shown on June 11, 2...
July 12, 2023, 4:23 pm
Marvel discovery bolsters board with veteran geologist peter born
Marvel Discovery Corp is adding strength to its board of directors with the appointment of veteran geologist Peter Born. As an experienced geologist w...
July 11, 2023, 12:59 pm
Mirum: must watch biotech on release of results from embark study
Results from the phase 2b EMBARK study, which is using LIMVARLI for the treatment of patients with biliary atresia, are expected in the 2nd half of 20...
July 9, 2023, 11:01 am
Replimune: the rise of oncolytic virus therapies in cancer treatment
The company's RPx platform, featuring RP1, RP2, and RP3, showcases a comprehensive and innovative approach to cancer treatment. Top-line results from ...
July 9, 2023, 1:22 am
Reasons to retain shockwave medical (swav) in your portfolio
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies<...
July 7, 2023, 9:23 am
Ultragenyx (rare) doses first patients in bone disease studies
Ultragenyx (RARE) announces dosing the first patients in its phase III studies evaluating setrusumab (U...
July 7, 2023, 9:23 am
Spero therapeutics: the multi-asset pipeline could outpace the tebipenem hbr deal with gsk
Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreem...
July 5, 2023, 3:06 pm
Cassava sciences: why market skepticism persists despite positive findings on simufilam
Cassava Sciences' Alzheimer's drug, simufilam, reduced cognitive decline by 38% in a small study, but the results were not statistically significant, ...
July 5, 2023, 3:05 pm
Journey medical (derm) to post skin disease data, stock rises 26%
Journey Medical (DERM) rises 26% on Monday after announcing the tentative date for reporting top-line results from its late-stage ...
July 4, 2023, 9:14 am
Community association services of indiana hosts free webinar on reserve study and maintenance plans for managed community board members
CARMEL, Ind., July 03, 2023 (GLOBE NEWSWIRE) — Associa Community Association Services of Indiana (CASI) invites you to attend its upcoming board edu...
July 3, 2023, 11:58 am
Nls pharmaceutics shares rise as narcolepsy treatment moves to phase 3 studies
Shares of NLS Pharmaceutics Ltd. NLSP, +19.57% gained 12% premarket on Monday after the Swiss clinical-stage biopharma company said it would proceed w...
July 3, 2023, 8:53 am
Hologic: additional critical factors forming bullish thesis, reiterate buy
Hologic continues to present with attractive business economics and robust fundamentals ex-Covid. There are additional critical factors to consider, i...
July 1, 2023, 5:25 am
Allovir: several late-stage programs make this worth a look
Positive final results from the phase 2 study, using posoleucel for BK Virus, were presented at the American Transplant Congress 2023. Discussions wit...
July 1, 2023, 3:48 am
Highgold mining starts 2023 exploration program at johnson tract polymetallic gold project in alaska
HighGold Mining Inc (TSX-V:HIGH, OTCQX:HGGOF) said it has started its 2023 exploration program at the Johnson Tract (JT) polymetallic Gold Project in ...
June 29, 2023, 8:11 am
Climate event el niño could hit the economy from food prices to clothing sales this year
The phenomenon not only has an impact on weather conditions, but studies also show it can cause ripple ...
June 29, 2023, 7:28 am
Usd/jpy: bulls look for further upside but markets remain cautious about possible intervention
USDJPY keeps firm bullish tone and trading near new multi-month high in European session on Tuesday, as bulls regain traction after pausing on Monday....
June 27, 2023, 9:46 am
New developments in weight-loss drugs: novo nordisk, eli lilly & pfizer advance studies
Dr. Angela Fitch, Knownwell chief medical officer and president of Obesity Medicine Association, joins 'Squawk Box' to discuss the advances in weight-...
June 27, 2023, 7:40 am
Iq-ai sent 4% higher following recent successful pre-clinical studies
IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF), the company focused on delivering imaging platforms to treat patients more effectively, enjoyed a boost on the Lond...
June 27, 2023, 5:55 am